Last reviewed · How we verify
Vasovist
At a glance
| Generic name | Vasovist |
|---|---|
| Sponsor | Guy's Hospital |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases (PHASE2)
- Renal MRA Crossover Study Comparing Multihance to Another Contrast Agent (PHASE3)
- Feraheme As An MRI Contrast Agent For Pediatric Congenital Heart Disease (PHASE4)
- Pulmonary MR Angiography and Lower Extremity MR Venous Imaging Using Gadofosveset (Ablavar)
- Detection of Liver Fibrosis With Magnetic Resonance Imaging (MRI) (PHASE4)
- Gadofosveset Trisodium for Heart Imaging Studies
- Imaging of Totally Blocked Arteries (PHASE1)
- Diagnostic Value of Novel MR Imaging Techniques for the Primary Staging and Restaging of Rectal Cancer
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Vasovist CI brief — competitive landscape report
- Vasovist updates RSS · CI watch RSS
- Guy's Hospital portfolio CI